Other lipid agents × all-cause mortality

TrialThe New England journal of medicine2010

Effects of combination lipid therapy in type 2 diabetes mellitus.

ACCORD Study Group et al.PubMed ↗Full text ↗Publisher ↗

What the trial testedas reported · 5,518 people · 2010

Range includes no effect

No clear effect on deaths

−9%−25% to +10%

About 2 in 100 either way

Bigger than 3 in 10 for all-cause mortality

As reported

HR 0.91, 95% CI 0.75–1.10 · the paper's word: All-cause mortality

One number in the abstract

the abstract, start to end

1.6% in the placebo group (hazard ratio, 0.91; 95% CI, 0.75 to 1.10; P=0.33).

← favours treatmentfavours comparator →
could be chance
All-cause mortality
HR 0.910.75–1.10
Other lipid agentsAll-cause mortality

Other lipid agents × all-cause mortalityhelps?one trial

unlikelylikely
0.500.50 without it
← favours treatmentfavours comparator →
more certainless certain
1 / 5

943 papers cite itlatest 60 shown

2010
2022
2023
2024
2025
2026
this paperpooled ittrialcites it

4 trials

Full record →Abstract, authors, funding and every citing paper · PMID 20228404